Company Filing History:
Years Active: 1998-2000
Title: Yiping Fu: Innovator in Monospecific Antibodies
Introduction
Yiping Fu is a prominent inventor based in New York, NY (US). He has made significant contributions to the field of biotechnology, particularly in the development of monospecific antibodies. With a total of 3 patents, his work has implications for diagnostics and therapeutic applications.
Latest Patents
Yiping Fu's latest patents focus on monospecific antibodies against a subunit of fibrinogen. The invention provides antibodies that are specifically reactive with the .alpha.E subunit of fibrinogen or its fragments, while not interacting with other portions of the fibrinogen molecule. Additionally, the invention includes anti-.alpha.E probes, which consist of detectably labeled monospecific anti-.alpha.E antibodies. Methods for using these antibodies for the detection of the .alpha.E subunit and its fragments are also provided, along with reagents and kits for performing these methods. Furthermore, diagnostic methods associated with atherogenesis, thrombogenesis, and pregnancy status are outlined. The invention also offers continuous cell lines that produce monospecific anti-.alpha.E antibodies.
Career Highlights
Yiping Fu is affiliated with the New York Blood Center, Inc., where he continues to advance research in his field. His innovative work has garnered attention and respect within the scientific community.
Collaborations
Yiping Fu has collaborated with notable colleagues, including Gerd Grieninger and Yan Cao, contributing to the advancement of research in biotechnology.
Conclusion
Yiping Fu's contributions to the field of biotechnology, particularly through his patents on monospecific antibodies, highlight his role as an influential inventor. His work continues to impact diagnostics and therapeutic strategies in medicine.